Regina Fritsche Danielson

Regina Fritsche Danielson is an accomplished professional in the field of cardiovascular research and development, currently serving as Senior Vice President and Global Head of Research and Early Clinical Development for CVRM at AstraZeneca since October 2007. With a robust background that includes roles as Vice President and Head of the IMED CVRM Biotech Unit, and prior leadership positions focused on Vascular Disease Prevention, Regina has significantly contributed to the advancement of therapies addressing atherosclerotic cardiovascular disease. Regina's academic qualifications include an Associate Professorship in Animal Physiology from the University of Gothenburg, postdoctoral research at the University of Nevada-Las Vegas, and multiple PhDs in Cardiovascular Physiology from institutions such as the University of Gothenburg and the University of Ottawa.